August 7, 2018 : DCMS #409

DISASTERS AVERTED — Near Miss Case Studies

The Specialty of Diabetes Care During Pregnancy

EXCLUSIVE INTERVIEW — Candid Video Interviews with Top Practitioners

Ji Hyun Chun on the Role of Endocrine PAs

HOMERUN SLIDES — Great Clinical Presentation Highlights

Pathophysiology of Type 1 Diabetes Part 3

CLINICAL GEMS — The Best from Diabetes Texts

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #137: Pathogenesis of Type 2 Diabetes Mellitus Part 8

MOST POPULAR ARTICLES OF THE MONTH

#1 37-Year-Old Hypertensive Drug Improves Beta Cell Function and Insulin Production
#2 New Omnipod® Closed-Loop Insulin Delivery System Improves Glycemic Control
#3 One More Benefit for SGLT-2 Inhibitors

Every time I look in the endocrinology journals and magazines, the last 4 or 5 pages are always chock full of employment opportunities for endocrinologists all over the country. Many of these ads are the same month after month, giving the indication of just how hard it is to find enough endocrinologists to take care of our burgeoning numbers of complex diabetes patients. One of the ways this shortage is being addressed is with the growth of physician assistants as endocrinology experts. What is their training and how do they impact patients in endocrinology practices all over the country?

Our publisher, Steve Freed, sat down with Ji Hyun Chun (CJ), MPAS, PA-C, BC-ADM, current President of the American Society of Endocrine Physician Assistants, at the recent AACE meeting, and together they discussed what a Endocrine PA is and what they do.

Dave Joffe

Editor-in-chief

A patient who has had type 1 diabetes became pregnant after nearly 20 years of having type 1 diabetes. She reported her OB-GYN referred her to a specialty clinic for high-risk pregnancy, including diabetes in pregnancy. They worked in tandem to ensure her care was carefully managed throughout the stages of her pregnancy.

Ji Hyun Chun (CJ), PA-C, MPAS, BC-ADM, received his Bachelor’s degree in Exercise Science at Arizona State University and Master of Physician Assistant Study at A.T.Still University/Arizona School of Health Science. CJ is the current president of American Society of Endocrine PAs and practices endocrinology at OptumCare Medical Group in Orange County, California. He also serves on editorial board for Clinician Reviews and peer reviewer for Journal of AAPA.

In this week’s Homerun Slides, the general concept of insulin pump therapy and CGM patterns.

Glucose transport: Activation of the insulin signal transduction system in insulin target tissues stimulates glucose transport via a mechanism that involves translocation of a large intracellular pool of glucose transporters (associated with low-density microsomes) to the plasma membrane and their subsequent activation after insertion into the cell membrane.

Researchers discover safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset type 1.

Hybrid closed-loop (HCL) system combines technology of CGM and insulin pumps, and a personalized, model-predictive control algorithm to deliver insulin day and night.

Treatment method reduced the amount of liver fat more than standard treatment alone.